Relationships of PAI-1 4G/5G polymorphism and conventional risk factors for coronary artery disease with the severity of coronary stenosis

被引：0
|
作者：
Rattanawan, C. [1 ]
Komanasin, N. [1 ]
Settasatian, N. [1 ]
Settasatian, C. [2 ]
Kukongviriyapan, U. [2 ]
Intharapetch, P. [3 ]
Duangsorn, S. [4 ]
Tantipanichteerakul, K. [4 ]
Senthong, V [3 ]
机构：
[1] Khon Kaen Univ, Northeast Hosp, Fac Associated Med Sci, Khon Kaen, Thailand
[2] Khon Kaen Univ, Northeast Hosp, Fac Med, Cardiovasc Res Grp, Khon Kaen, Thailand
[3] Khon Kaen Univ, Northeast Hosp, Cardiovasc Res Grp, Khon Kaen, Thailand
[4] Khon Kaen Univ, Northeast Hosp, Queen Sirikit Heart Ctr, Khon Kaen, Thailand
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-TU-261
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
  • [21] PAI-1 mRNA expression and plasma level in rheumatoid arthritis: relationship with 4G/5G PAI-1 polymorphism
    Francisco Munoz-Valle, Jose
    Luz Ruiz-Quezada, Sandra
    Oregon-Romero, Edith
    Elena Navarro-Hernandez, Rosa
    Castaneda-Saucedo, Eduardo
    De la Cruz-Mosso, Ulises
    Illades-Aguiar, Berenice
    Antonio Leyva-Vazquez, Marco
    Castro-Alarcon, Natividad
    Parra-Rojas, Isela
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (12) : 3951 - 3956
  • [22] 4G/5G polymorphism modulates PAI-1 circulating levels in obese women
    Fernandes, Karla S.
    Sandrim, Valeria C.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2012, 364 (1-2) : 299 - 301
  • [23] PAI-1 4G/5G polymorphism and antiphospholipid antibodies (APA) in pregnancy complications
    Bellia, M.
    Apergis, G.
    Gafou, A.
    Nomikou, E.
    Pevlou, E.
    Zafiri, C.
    Andrioti, E.
    BLOOD REVIEWS, 2007, 21 : S104 - S105
  • [24] The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS
    Tsangaris, Iraklis
    Tsantes, Argiris
    Bonovas, Stefanos
    Lignos, Michalis
    Kopterides, Petros
    Gialeraki, Argiro
    Rapti, Evdoxia
    Orfanos, Stylianos
    Dimopoulou, Ioanna
    Travlou, Anthi
    Armaganidis, Apostolos
    THROMBOSIS RESEARCH, 2009, 123 (06) : 832 - 836
  • [25] PAI-1 −675 4G/5G polymorphism as a prognostic biomarker in breast cancer
    Haixin Lei
    Kari Hemminki
    Robert Johansson
    Andrea Altieri
    Kerstin Enquist
    Roger Henriksson
    Per Lenner
    Asta Försti
    Breast Cancer Research and Treatment, 2008, 109 : 165 - 175
  • [26] 4G/5G polymorphism modulates PAI-1 circulating levels in obese women
    Karla S. Fernandes
    Valéria C. Sandrim
    Molecular and Cellular Biochemistry, 2012, 364 : 299 - 301
  • [27] Diabetic microangiopathy and 4G/5G polymorphism of the PAI-1 gene promoter in IDDM
    Pucci, L
    Pilo, M
    Bandinelli, S
    Navalesi, R
    Penno, G
    DIABETES, 1999, 48 : A153 - A153
  • [28] Plasminogen activator inhibitor I (PAI-I) -675 5G/4G polymorphism in patients with coronary artery disease
    Apergis, G
    Belia, M
    Bratsas, A
    Pavlou, E
    Brili, S
    Gafou, A
    Georgopoulos, J
    Stefanadis, C
    Andrioti, E
    PROCEEDINGS OF THE 18TH INTERNATIONAL CONGRESS ON THROMBOSIS, 2004, : 31 - 35
  • [29] 4G/5G polymorphisms of PAI-1 in the metabolic syndrome
    Roncal, C
    Orbe, J
    Rodríguez, JA
    Páramo, JA
    MEDICINA CLINICA, 2006, 126 (06): : 234 - 234
  • [30] PAI-1 gene polymorphism and modifiable risk factors of coronary artery disease
    Saber-Ayad, M. M.
    Latif, I.
    Mahmoud, S.
    Salah, Y.
    Ramadan, Y.
    Taher, E.
    Shafy, S.
    Marrie, A.
    Ghaleb, H.
    Mokhtar, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 1000 - 1000
12345